[Clinical studies with the new saluretic azosemide].
It is reported on the clinical experiences with the new diuretic azosemid in 22 patients with oedemas of various genesis. Azosemid displays the characteristics of a very effective and well tolerated saluretic. After intensive treatment azosemid exerts similar side effects on the electrolyte (hyponatraemia, hypokalaemia, hypochloraemia) and purine metabolism (hyperuricaemia) as furosemide. Since azosemid is a very effective and well tolerated diuretic with no serious side effects it seems that it is a valuable extension of the contemporary diuretic therapy.
D000328:Adult; D000368:Aged; D004232:Diuretics / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy*; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy*; D011507:Proteinuria / Q000175:diagnosis; D013424:Sulfanilamides / Q000627:therapeutic use*; D013777:Tetrazoles; D013876:Thiophenes; D000096926:Benzenesulfonamides
D004232:Diuretics; D013424:Sulfanilamides; C018222:azosemide; D013777:Tetrazoles; D013876:Thiophenes; D000096926:Benzenesulfonamides
Klinische Untersuchungen mit dem neuen Saluretikum Azosemid.